Regeneron Pharmaceuticals Inc (REGN)
- Exchange
- NASDAQ
- Symbol
- REGN
- Sector
- Life Sciences
- Industry
- Pharmaceutical Preparations
- Description
- Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.
- Country
- USA
Stock price
At close: November 21, 2024
-
Open744.87
-
High757.56
-
Low735.95
-
Close744.50
-
Volume971,881
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
1.10
Receivables turnover
2.30
Payables turnover
4.68
Working capital turnover
0.81
Days of inventory on hand (DOH)
331.61
Days of sales outstanding (DSO)
158.58
Number of days of payables
77.95
Fixed asset turnover
3.68
Total asset turnover
0.39
Current ratio
5.69
Quick ratio
4.82
Cash ratio
3.17
Cash conversion cycle
412.24
Debt-to-assets ratio
0.06
Debt-to-capital ratio
0.07
Debt-to-equity ratio
0.08
Financial leverage ratio
1.27
Interest coverage
58.52
Gross profit margin
78.23%
Operating profit margin
31.03%
Pretax margin
32.19%
Net profit margin
30.31%
Operating return on assets (Operating ROA)
12.23%
Return on assets (ROA)
11.95%
Return on total capital
15.28%
Return on equity (ROE)
15.22%